Latest stories

  • in

    NPPA Revises Ceiling Price of Dextrose Injection 25% w/v

    New Delhi: In accordance with the price revision as per the annual wholesale price index (WPI) of 12.1218%, through a recent a recent notification, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilisers, the Government of India has revised and fixed the ceiling price of Dextrose Injection (25% w/v) in 100 ml […] More

  • in

    Dr Reddys Labs unveils Treprostinil Injection in US

    Hyderabad: Dr. Reddy’s Laboratories Ltd. has announced the launch of Treprostinil Injection in the U.S. market, a therapeutic equivalent generic version of Remodulin (treprostinil) Injection, approved by U. S. Food and Drug Administration (USFDA).  Treprostinil injection is a prostacyclin mimetic indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to diminish symptoms associated […] More

  • in

    NPPA revises ceiling price of Metronidazole Injection 0.5%w/v

    New Delhi:In accordance with price revision as per the annual wholesale price index (WPI) of 12.1218% increase, through a recent notification, the National Pharmaceuticals Pricing Authority (NPPA), the Ministry of Chemicals and Fertilisers, the Government of India, has revised and fixed the ceiling price of the metronidazole injection (0.5% w/v) under the Drug (Price Control) […] More

  • in

    Zydus Lifesciences bags USFDA okay for Isoproterenol Hydrochloride Injection

    Zydus Lifesciences bags USFDA okay for Isoproterenol Hydrochloride Injection

    Ahmedabad: Drugmaker, Zydus Lifesciences Limited, has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Isoproterenol Hydrochloride Injection USP, 0.2 mg/mL and 1 mg/5 mL (0.2 mg/mL) single-dose vials (USRLD: Isuprel Injection). Isoproterenol hydrochloride injection is indicated to improve hemodynamic status in patients in distributive shock and shock […] More